Zhejiang Medicine Co Ltd
SSE:600216
Zhejiang Medicine Co Ltd
SSE:600216
Price:
13.66
CNY
-1.3%
Market Cap:
13.1B
CNY
Balance Sheet
Balance Sheet Decomposition
Zhejiang Medicine Co Ltd
Zhejiang Medicine Co Ltd
| Current Assets | 6.1B |
| Cash & Short-Term Investments | 2B |
| Receivables | 2B |
| Other Current Assets | 2.1B |
| Non-Current Assets | 7.3B |
| Long-Term Investments | 243.2m |
| PP&E | 6.2B |
| Intangibles | 717.3m |
| Other Non-Current Assets | 139.2m |
Balance Sheet
Zhejiang Medicine Co Ltd
Zhejiang Medicine Co Ltd
Currency: CNY
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 279
|
1 163
|
1 317
|
1 417
|
1 492
|
1 278
|
1 629
|
1 769
|
1 438
|
1 460
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 769
|
1 438
|
1 460
|
|
| Cash Equivalents |
1 279
|
1 163
|
1 317
|
1 417
|
1 492
|
1 278
|
1 629
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
299
|
274
|
480
|
321
|
457
|
447
|
328
|
|
| Total Receivables |
1 244
|
1 325
|
1 469
|
1 796
|
1 741
|
1 795
|
1 648
|
1 872
|
1 675
|
1 685
|
|
| Accounts Receivables |
839
|
916
|
1 012
|
1 301
|
1 259
|
1 413
|
1 175
|
1 444
|
1 298
|
1 252
|
|
| Other Receivables |
405
|
409
|
457
|
495
|
482
|
382
|
473
|
428
|
377
|
433
|
|
| Inventory |
812
|
860
|
1 028
|
971
|
1 192
|
1 435
|
1 480
|
1 873
|
1 995
|
2 011
|
|
| Other Current Assets |
49
|
49
|
31
|
30
|
34
|
51
|
40
|
64
|
101
|
118
|
|
| Total Current Assets |
3 384
|
3 397
|
3 845
|
4 513
|
4 734
|
5 039
|
5 118
|
6 035
|
5 655
|
5 601
|
|
| PP&E Net |
3 675
|
4 070
|
4 203
|
4 423
|
4 460
|
4 496
|
4 556
|
5 422
|
5 673
|
6 066
|
|
| PP&E Gross |
3 675
|
4 070
|
4 203
|
4 423
|
4 460
|
4 496
|
4 556
|
5 422
|
5 673
|
6 066
|
|
| Accumulated Depreciation |
1 141
|
1 424
|
1 738
|
2 017
|
2 326
|
2 780
|
3 175
|
3 747
|
4 285
|
4 811
|
|
| Intangible Assets |
347
|
409
|
425
|
407
|
408
|
407
|
410
|
729
|
748
|
744
|
|
| Goodwill |
0
|
0
|
12
|
12
|
5
|
0
|
0
|
36
|
28
|
19
|
|
| Long-Term Investments |
438
|
348
|
299
|
369
|
367
|
315
|
299
|
226
|
242
|
261
|
|
| Other Long-Term Assets |
25
|
24
|
31
|
69
|
74
|
106
|
119
|
84
|
87
|
89
|
|
| Other Assets |
0
|
0
|
12
|
12
|
5
|
0
|
0
|
36
|
28
|
19
|
|
| Total Assets |
7 869
N/A
|
8 249
+5%
|
8 814
+7%
|
9 793
+11%
|
10 048
+3%
|
10 362
+3%
|
10 500
+1%
|
12 532
+19%
|
12 433
-1%
|
12 780
+3%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
942
|
1 028
|
917
|
872
|
776
|
757
|
674
|
1 389
|
1 029
|
1 130
|
|
| Accrued Liabilities |
46
|
54
|
69
|
147
|
156
|
140
|
252
|
293
|
271
|
259
|
|
| Short-Term Debt |
159
|
367
|
335
|
324
|
426
|
674
|
275
|
274
|
91
|
228
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
14
|
108
|
0
|
200
|
450
|
550
|
370
|
|
| Other Current Liabilities |
45
|
55
|
271
|
460
|
420
|
479
|
523
|
619
|
525
|
491
|
|
| Total Current Liabilities |
1 192
|
1 505
|
1 592
|
1 817
|
1 887
|
2 051
|
1 924
|
3 025
|
2 465
|
2 478
|
|
| Long-Term Debt |
0
|
20
|
135
|
120
|
12
|
0
|
501
|
251
|
201
|
231
|
|
| Deferred Income Tax |
56
|
47
|
40
|
29
|
22
|
23
|
11
|
21
|
2
|
0
|
|
| Minority Interest |
23
|
20
|
14
|
490
|
437
|
391
|
355
|
403
|
450
|
356
|
|
| Other Liabilities |
60
|
61
|
56
|
48
|
43
|
37
|
34
|
53
|
54
|
84
|
|
| Total Liabilities |
1 331
N/A
|
1 653
+24%
|
1 836
+11%
|
2 504
+36%
|
2 401
-4%
|
2 502
+4%
|
2 826
+13%
|
3 753
+33%
|
3 173
-15%
|
3 149
-1%
|
|
| Equity | |||||||||||
| Common Stock |
936
|
936
|
963
|
966
|
965
|
965
|
965
|
965
|
965
|
965
|
|
| Retained Earnings |
4 380
|
4 485
|
4 889
|
5 002
|
5 290
|
5 611
|
5 371
|
6 195
|
6 417
|
6 682
|
|
| Additional Paid In Capital |
910
|
910
|
1 090
|
1 279
|
1 349
|
1 343
|
1 398
|
1 692
|
1 941
|
2 005
|
|
| Treasury Stock |
0
|
0
|
188
|
125
|
82
|
60
|
60
|
60
|
58
|
28
|
|
| Other Equity |
313
|
264
|
225
|
167
|
125
|
1
|
0
|
14
|
5
|
6
|
|
| Total Equity |
6 538
N/A
|
6 595
+1%
|
6 978
+6%
|
7 289
+4%
|
7 647
+5%
|
7 861
+3%
|
7 675
-2%
|
8 779
+14%
|
9 260
+5%
|
9 631
+4%
|
|
| Total Liabilities & Equity |
7 869
N/A
|
8 249
+5%
|
8 814
+7%
|
9 793
+11%
|
10 048
+3%
|
10 362
+3%
|
10 500
+1%
|
12 532
+19%
|
12 433
-1%
|
12 780
+3%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
936
|
936
|
936
|
966
|
958
|
958
|
958
|
958
|
958
|
962
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
